• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

11/12/2025 11:54

Alembic Pharmaceutic - Press Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled ""Alembic Pharmaceuticals Limited receives USFDA Final Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3%"".